Champlain Investment Partners LLC decreased its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 11.4% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 409,342 shares of the technology company’s stock after selling 52,760 shares during the period. Champlain Investment Partners LLC’s holdings in Novanta were worth $62,535,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Arizona State Retirement System grew its holdings in Novanta by 0.7% in the 4th quarter. Arizona State Retirement System now owns 10,412 shares of the technology company’s stock valued at $1,591,000 after buying an additional 76 shares during the period. Envestnet Portfolio Solutions Inc. raised its stake in Novanta by 5.6% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 1,687 shares of the technology company’s stock worth $258,000 after purchasing an additional 90 shares during the period. Huntington National Bank boosted its holdings in shares of Novanta by 53.6% in the 4th quarter. Huntington National Bank now owns 430 shares of the technology company’s stock valued at $66,000 after purchasing an additional 150 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Novanta during the 4th quarter valued at $26,000. Finally, Moran Wealth Management LLC increased its holdings in shares of Novanta by 9.4% during the 4th quarter. Moran Wealth Management LLC now owns 3,241 shares of the technology company’s stock worth $495,000 after buying an additional 278 shares during the last quarter. 98.35% of the stock is owned by hedge funds and other institutional investors.
Novanta Price Performance
NOVT opened at $114.02 on Thursday. Novanta Inc. has a 52-week low of $98.76 and a 52-week high of $187.12. The company has a 50 day moving average of $132.64 and a two-hundred day moving average of $152.73. The company has a market cap of $4.10 billion, a P/E ratio of 68.28 and a beta of 1.42. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61.
Analyst Ratings Changes
Separately, Robert W. Baird cut their price objective on Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a report on Monday, March 3rd.
View Our Latest Stock Report on Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Articles
- Five stocks we like better than Novanta
- The How And Why of Investing in Oil Stocks
- Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility
- How to Short a Stock in 5 Easy StepsĀ
- Spotify Stock Climbs as Its Growth Strategy Diversifies
- How to Short Nasdaq: An Easy-to-Follow Guide
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.